Type
|
Public |
---|---|
Traded as | TSX: NTB NASDAQ: NEPT |
Industry | Health, Wellness |
Founded | October 9, 1998 |
Headquarters | Laval, Quebec, Canada |
Area served
|
Over 30 Countries Worldwide |
Key people
|
Jim Hamilton, President, CEO,Mario Paradis, CFO, Michel Timperio, Head of Strategic Development |
Number of employees
|
Est. 125 (2016) |
Subsidiaries | Acasti Pharma |
Website | www.neptunecorp.com www.oceano3.com |
Neptune Wellness Solutions is a nutrition products company focused on the business of customized unique nutrition solutions, specialty ingredients and consumer brands. The company develops turnkey solutions available in various unique delivery forms. Neptune also offers specialty ingredients, including premium Neptune Krill Oil (NKO) manufactured in its state-of-the art facility and a variety of other marine oils, seed oils and specialty ingredients. Neptune offers its premium krill oil under the OCEANO3® brand directly to consumers in Canada and the United States through web sales at www.oceano3.com. Oceano3 brand is also sold in bulk to unbranded distributors. The Company’s head office is located in Laval, Quebec.
Neptune is also pursuing opportunities in the prescription drug markets, through its approximately 48% owned subsidiary Acasti Pharma Inc. (“Acasti”). Acasti focuses on the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment of severe hypertriglyceridemia.
Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q2 2022 | 2023-02-12 | Future report Set alerts | |
Q1 2022 | 2022-08-15 | -0.92 | -0.92 |
Q4 2021 | 2022-06-13 | 0.00 | 0.00 |
Q3 2021 | 2022-02-10 | -0.11 | -0.11 |
Q2 2021 | 2021-11-15 | -0.11 | -0.11 |
Q1 2021 | 2021-08-10 | -0.14 | -0.14 |
Q4 2020 | 2021-07-15 | -0.43 | -0.43 |
Q3 2020 | 2021-02-15 | -0.16 | -0.16 |
Q1 2020 | 2020-08-11 | -0.13 | -0.11 |
Q4 2019 | 2020-06-10 | -0.44 | -0.41 |
In NEPT 0 funds of 2213 total. Show all
Fund name | Ticker shares |
---|